Infectious Causes Of Cancer Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Infectious Causes Of Cancer stocks.

Infectious Causes Of Cancer Stocks Recent News

Date Stock Title
May 10 INSM Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript
May 10 QDEL QuidelOrtho Corp Reports Mixed Q1 2024 Results Amid Strategic Shifts and Market Challenges
May 10 INSM Insmed Inc (INSM) Reports Q1 2024 Earnings: Misses EPS Estimates, Revenue Grows Amidst Clinical ...
May 10 INSM Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
May 10 AEMD Aethlon jumps on positive results from in vitro binding study of Hemopurifier device
May 10 AEMD Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
May 10 INSM Insmed First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 9 INSM Insmed, Inc. (INSM) Q1 2024 Earnings Call Transcript
May 9 QDEL QuidelOrtho Corporation (NASDAQ:QDEL) Q1 2024 Earnings Call Transcript
May 9 INSM Insmed (INSM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
May 9 INSM Insmed (INSM) Reports Q1 Loss, Lags Revenue Estimates
May 9 INSM Insmed reports mixed Q1 results; reaffirms FY24 outlook
May 9 INSM Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update
May 9 QDEL QuidelOrtho Corp (QDEL) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ...
May 9 QDEL QuidelOrtho Corporation (QDEL) Q1 2024 Earnings Call Transcript
May 8 QDEL QuidelOrtho Corporation 2024 Q1 - Results - Earnings Call Presentation
May 8 QDEL Quidel Non-GAAP EPS of $0.44 beats by $0.04, revenue of $711M beats by $15.87M
May 8 QDEL QuidelOrtho Reports First Quarter 2024 Financial Results
May 8 INSM Insmed Q1 2024 Earnings Preview
May 8 INSM Should You Buy Insmed (INSM) Ahead of Earnings?
Infectious Causes Of Cancer

Browse All Tags